Speaker illustration

Doctor Nandakumar Ramakrishnan

National Heart Institute, Kuala Lumpur (Malaysia)

Role of new oral anticoagulants in left atrial occluder device implants

Event: ESC Congress 2018

Topic: Left Atrial Appendage Closure

Session: Atrial fibrillation - Stroke prevention 3

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb